Surface charge dynamics on ferroelectric PbZr0.48Ti0.52O3 films responding to the switching bias of electric force microscope

We investigated the role of surface charges in writing and reading ferroelectric bits on an epitaxial PbZr0.48Ti0.52O3 thin film by electric force microscopy (EFM). The sign of EFM surface potential was reversed within several hundred microseconds for 10 V. For a negative bias voltage of -10 V, EFM surface potential was reversed in several milliseconds. The different time scales of the EFM surface potential reversals originate from the screening of the ferroelectric polarization charges by the surface charges which pass over two different Schottky barriers depending on the applied bias polarity.X118sciescopu

Self-assembly of Oligomeric Linear Dipyrromethene Metal Complexes

BF2 capped dipyrrin dimers were synthesized and have been used to terminate oligomerization to form a series of controlled length oligomers; the crystal structures of the metal complexes were investigated and correlations between the structures and optical properties were established.open114341sciescopu

Association Between Proton Pump Inhibitor Use During Early Pregnancy and Risk of Congenital Malformations

Importance: Proton pump inhibitors (PPIs) are increasingly used during pregnancy; however, several observational studies have raised concerns about an increased risk of specific types of congenital malformations. Objective: To examine the association between PPI exposure during early pregnancy and the risk of congenital malformations. Design, Setting, and Participants: This population-based cohort study used data from the National Health Insurance Service-National Health Information Database of South Korea (2010-2020); sibling-controlled analyses were conducted to account for familial factors. A total of 2 696 216 pregnancies in women aged 19 to 44 years between June 1, 2011, and December 31, 2019, and their live-born infants were identified. Pregnant women who were exposed to known teratogens or who delivered infants with chromosomal abnormalities or genetic syndromes were excluded. Data on participant race and ethnicity were not collected because the National Health Information Database does not report this information. Exposures: Proton pump inhibitor use during the first trimester. Main Outcomes and Measures: Primary outcomes were major congenital malformations, congenital heart defects, cleft palate, hydrocephalus, and hypospadias. The subtypes of major congenital malformations and congenital heart defects were evaluated as exploratory outcomes. Propensity score fine stratification was used to control for potential confounders, and a weighted generalized linear model was used to estimate relative risks with 95% CIs. Results: Of 2 696 216 pregnancies (mean [SD] maternal age, 32.1 [4.2] years), 40 540 (1.5%; mean [SD] age, 32.4 [4.6] years) were exposed to PPIs during the first trimester. The absolute risk of major congenital malformations was 396.7 per 10 000 infants in PPI-exposed pregnancies and 323.4 per 10 000 infants in unexposed pregnancies. The propensity score-adjusted relative risks were 1.07 (95% CI, 1.02-1.13) for major congenital malformations, 1.09 (95% CI, 1.01-1.17) for congenital heart defects, 1.02 (95% CI, 0.72-1.43) for cleft palate, 0.94 (95% CI, 0.54-1.63) for hydrocephalus, and 0.77 (95% CI, 0.51-1.17) for hypospadias. In the sibling-controlled analyses, no associations were observed between PPI use and primary outcomes, including major congenital malformations (odds ratio, 1.05; 95% CI, 0.91-1.22) and congenital heart defects (odds ratio, 1.07; 95% CI, 0.88-1.30). A range of sensitivity analyses revealed results that were similar to the main findings. Conclusions and Relevance: In this cohort study, the use of PPIs during early pregnancy was not associated with a substantial increase in the risk of congenital malformations, although small increased risks were observed for major congenital malformations and congenital heart defects; findings from sibling-controlled analyses revealed that PPIs were unlikely to be major teratogens. These findings may help guide clinicians and patients in decision-making about PPI use in the first trimester

Bernardin Frankapan i Krbavska bitka: je li spasio sebe i malobrojne ili je pobjegao iz boja?

Veliki poraz hrvatske vojske od Osmanlija na Krbavskom polju 9. rujna 1493. predstavlja jednu od najvažnijih epizoda u dugotrajnom obrambenom ratu Hrvata protiv Osmanlija. Iako su uzroci i posljedice, pa i sam tijek bitke, već u znatnoj mjeri prikazani u starijoj i novijoj hrvatskoj historiografiji, ipak su uloga i djelovanje kneza Bernardina Frankapana u samoj bitki i događajima koji su joj prethodili, ostali u značajnoj mjeri nerasvijetljeni i nerazjašnjeni. Autor na osnovi sačuvanih pisanih i arheoloških svjedočanstva, kao i nakon uvida na terenu, analizira događaje koji su prethodili Bernardinovu povlačenju iz bitke, pokušavajući odgonetnuti uzroke i motive takova poteza. Isto tako, detaljnijim uvidom u sačuvana pisana svjedočanstva o događajima prije Krbavske bitke, pokušava objasniti odnose između bana Derenčina i knezova Frankapana.The great defeat of Croatian army against ottoman troops in the battle of Krbava field (9th September 1493) is one of the most important episode in long–lasting defensive war against Ottoman Empire. Although, the causes and the consequences, and the very duration of the battle, are already elaborated in older and newer Croatian historiography, the role and actions of the duke Bernardin Frankapan in the events before battle and in the battle are still not illuminated and dismissed. Analyzing the written sources and archeological artifacts, author describes events that are preceded Bernardin’s evacuation from the battle. He is, also, trying to figure out the motives and causes of such actions. Further more, by detailing analysis of written sources about events before battle of Krbava field, author clarifies relationships between banus Derenčin and ducal family of Frankapan

Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer

Extracellular vesicles (EVs) may play an important role in cancer development and progression. We aimed to investigate the prognostic potential of prostate-specific EVs in prostate cancer (PCa) patients. Plasma and prostate tissue were collected from patients who underwent surgery for PCa (n = 82) or benign prostatic hyperplasia (BPH, n = 28). To analyze the quantity of EVs in prostate, we performed transmission electron microscopy (TEM), immuno-TEM with CD63 and prostate-specific membrane antigen (PSMA), and immunofluorescence staining. After EV isolation from plasma, CD63 and PSMA concentration was measured using ELISA kits. PSMA-positive areas in prostate differed in patients with BPH, and low-, intermediate-, and high-risk PCa (2.4, 8.2, 17.5, 26.5%, p < 0.001). Plasma PSMA-positive EV concentration differed in patients with BPH, and low-, intermediate-, and high-risk PCa (21.9, 43.4, 49.2, 59.9 ng/mL, p < 0.001), and ROC curve analysis indicated that plasma PSMA-positive EV concentration differentiated PCa from BPH (AUC 0.943). Patients with lower plasma PSMA-positive EV concentration had greater prostate volume (50.2 vs. 33.4 cc, p < 0.001) and lower pathologic Gleason score (p = 0.025). During the median follow-up of 18 months, patients with lower plasma PSMA-positive EV concentration tended to have a lower risk of biochemical failure than those with higher levels of prostate-specific EVs (p = 0.085).11910Ysciescopu